UVM Health proposal to Green Mountain Care Board now open for public comment
The University of Vermont Health Network is taking action to address it's financial missteps.
For the past two years, the health network has gone far beyond it's revenue cap – a number set by the care board with the purpose of reducing the amount of money a hospital can make from caring for its patients.
The total overage for fiscal year 2023 was $80 million, in 2024 it was $53 million.
For the past three months, health network officials have been working alongside members of the care board to create a proposal they claim will address affordability, access, and reaffirm their commitment to the communities they serve.
That proposal was reviewed on Wednesday.
'Members of our community, members of this board have lost trust in our decisions. When that trust is compromised, we have an obligation to make it right,' says Dr. Sunny Eappen, Chief Executive Officer of the health network.
Some of the initiatives listed in the proposal include $11 million in investments in community based primary care, sending $12 million to Blue Cross Blue Shield Vermont to resolve overpayment allegations from fiscal year 2022 and 2023, and setting aside up to $15 million to hire a liaison that would work with both the health network and care board.
'That would really be a 'how do we work towards ensuring appropriate Medicare cost coverage, appropriate growth, operations – all those things as best we can for the state,' explains deputy director Matthew Sutter.
Some members of the community, however, voiced their concern.
'I am just beyond frusturated,' exclaims Alex LeClaire or Essex Physical Therapy.
'Can someone help me understand why we Vermonters, we rate payers, are paying up to $15 million for UVM health network to get their house in order,' questions Julie Wasserman.
The proposal has yet to be approved by the care board or the health network.
It has now entered a period of public comment, which will last for a week.
Chair Owen Foster says they hope to vote on it after that period.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
42 minutes ago
- Yahoo
ZoomCare Opens New Clinic in Happy Valley
The company will host an Open House for the community on Jun. 13 PORTLAND, Ore., June 10, 2025 /PRNewswire/ -- ZoomCare, a network of neighborhood clinics serving a wide variety of healthcare needs, today announced the opening of a new clinic to serve the community of Happy Valley. The new clinic is located at 17155 SE Sunnyside Road, Suite #160 in the Happy Valley Crossroads Shopping Center. The clinic will be open seven days a week. Staffed with board-certified providers who cater to a broad range of illnesses and injuries, the Happy Valley clinic will also include preventive care services. The location features five exam rooms and offers on-site labs and prescriptions, allowing patients to leave with medications in hand. Since 2006, ZoomCare has been known for its patient experience, which is focused on compassion, quality, and efficiency. "ZoomCare believes you shouldn't have to travel far to receive excellent care," said Jeff Fee, Chief Executive Officer of ZoomCare. "We are thrilled to join the Happy Valley community. Opening this new location aligns perfectly with our mission to make healthcare easy and accessible for everyone." The company will celebrate the new clinic opening with an Open House event on Friday, Jun. 13, from 11 a.m. - 2 p.m. The Open House is open to the public and will offer free specialty coffee drinks and Italian sodas, fun giveaways, and a chance to meet the provider team and see the new clinic space. "This Open House is an excellent opportunity for our providers and clinic staff to get to know the people of Happy Valley," said Jennifer Alemany, Director of Clinical Operations in Portland. "We hope folks will come by, meet our team, and learn more about how ZoomCare can help with their healthcare needs now and in the future!" ZoomCare accepts Medicare and Medicare Advantage at all of its 47 locations in Oregon and Washington. Using Medicare-certified software platform Athenahealth, ZoomCare can access and share electronic health records with other providers and health systems. This certified software platform also lets ZoomCare establish partnerships with large health systems and insurance plans to increase patient access to primary, urgent, emergency, and specialty care. About ZoomCareZoomCare's vision is to make healthcare easy. Founded in 2006 in Portland, Oregon, ZoomCare operates more than 47 urgent, primary, emergency care, and specialty locations throughout Oregon and Washington. With conveniently located neighborhood clinics, plus evening and weekend hours, ZoomCare is committed to providing better access to healthcare and delivering evidence-based care with kindness at every visit. For more information, visit Follow ZoomCare on Facebook, Instagram, LinkedIn, and X. Media ContactAmanda Gibbs Director of Communications agibbs@ View original content to download multimedia: SOURCE ZoomCare
Yahoo
2 hours ago
- Yahoo
Biovica Announces Financial Targets Following Key Partnerships and Commercial Progress
UPPSALA, SE / / June 10, 2025 / Biovica International (STO:BIOVIC-B)(STO:BIOVIC.B)(FRA:9II) - Biovica, a leader in blood-based cancer monitoring, today announces financial goals for the upcoming two fiscal years. The targets reflect the company's recent commercial momentum and its long-term commitment to transparency and value creation for patients, healthcare providers, and shareholders. The recently communicated partner agreement with Tempus AI in the U.S. and the agreement with a leading healthcare provider, which was communicated in December 2024, are expected to generate significant revenues for Biovica. Along with more than 15 active collaborations with pharmaceutical companies representing a total project value of approximately 25 MSEK and the 18 active partnership agreements covering key European markets, the company has established a strong foundation for growth. On this basis, Biovica is now in a position to provide clear financial guidance. Biovica's financial targets: FY 2024/25 (ending April 30, 2025): Net sales of SEK 8.5 million FY 2025/26: Net sales of SEK 50 million FY 2026/27: Net sales of SEK 150 million With expected operating expenses at the current level of approximately 90 MSEK per year, Biovica anticipates becoming cash-flow positive during the third quarter of FY 2026/27. The expected distribution of revenues during FY25/26 and FY 26/27 are: 65% from the U.S. market, driven by reimbursement and volume growth through strategic partnerships 30% from pharma services, based on ongoing and future biomarker collaborations 5% from European partners, through distributor and lab agreements across 18 territories "These targets reflect the solid groundwork we have laid over the past years," says Anders Rylander, CEO of Biovica. "We've achieved clinical validation through world-leading oncologists and institutions, received FDA clearance, established a CMS/Medicare price, initiated commercial sales, and now secured strategic partnerships that enable us to scale up. The pieces are in place to deliver on our vision-improving outcomes for patients, optimizing care for providers, and generating long-term value for shareholders." Contact Anders Rylander, CEOPhone: +46 76 666 16 47E-mail: Anders Morén, CFOPhone: +46 73 125 92 46E-mail: Biovica - Treatment decisions with greater confidence Biovica develops and commercializes blood-based biomarker assays that help oncologists monitor cancer progression. Biovica's assay, DiviTum® TKa, measures cell proliferation by detecting the TKa biomarker in the bloodstream. The assay has demonstrated its ability to provide insight to therapy effectiveness in several clinical trials. The first application for the DiviTum® TKa test is treatment monitoring of patients with metastatic breast cancer. Biovica's vision is: "Improved care for cancer patients." Biovica collaborates with world-leading cancer institutes and pharmaceutical companies. DiviTum® TKa has received FDA 510(k) clearance in the US and is CE-marked in the EU. Biovica's shares are traded on the Nasdaq First North Premier Growth Market (BIOVIC B). FNCA Sweden AB is the company's Certified Adviser. For more information, please visit: This information is information that Biovica International is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, through the agency of the contact persons set out above, at 2025-06-10 18:31 CEST. Attachments Biovica announces financial targets following key partnerships and commercial progress SOURCE: Biovica International View the original press release on ACCESS Newswire
Medscape
2 hours ago
- Medscape
Years of Medicare Neglect Have Hurt Patients the Most
Every year, the cracks in the Medicare physician payment system widen. And with each year that Congress and the White House fail to act, physicians pay the price — and so do their patients. Patricia L. Turner, MD, MBA This year marks the fifth in a row physicians endured across-the-board cuts to Medicare payment, even as the cost of care climbs. Moreover, Congress and multiple administrations have neglected to meaningfully reform Medicare payments to physicians over the past 30 years. The consequences of this failure are manifesting in long times in waiting rooms, increased hospital visits, and decreased access to care. Keeping this in mind, we must dispel some common misconceptions about payment. Let us be clear: Physician payment is not the same as what doctors take home in salary. Those dollars are what keep practices afloat; ensure clinical and administrative staff are compensated; allow investments in new technology and clinical supplies; pay rent, utilities, and other overhead costs; and, most important, afford patients across the country timely access to any care they need, whether it be with primary care or a surgeon. R. Shawn Martin, MHCDS When the payments fail to cover the full scope of these costs, as is the case now, staff wages stagnate, appointments are shortened to increase the number of patient visits, and, in some cases, physicians may not be able to receive a salary of their own just to keep the practice afloat. Our country's physicians are burning out under these impossible choices, and future physicians are choosing other careers. We cannot afford to diminish our workforce when we need to grow it the most, given that our senior population is expected to double over the next 40 years. Communities suffer as a result. Patients are not just losing access to care; they are losing lifelong relationships with trusted physicians, and they are losing access to care for cancer and after trauma. Meanwhile, they are experiencing delayed access to preventive care and screening, more chronic disease, and worse outcomes after emergencies and hospitalizations, all of which cause healthcare costs to skyrocket. These are not hypothetical situations but are a bleak reality that cannot continue. The downstream effects don't stop with Medicare, which serves as a model for many state Medicaid agencies, managed care plans, and private payers. When Medicare underpays, costs everywhere are driven down, deepening the strain on practices and widening gaps in access for all patients. Outdated payments are particularly concerning given that other areas within healthcare, including hospitals, skilled nursing facilities, and other facilities, are seeing significant increases in payments. Physicians are glaringly absent from this list. Primary care clinicians often are the first line of care for patients in communities large and small and rural and urban. Patients also risk losing critical access to surgical care. Many communities already lack enough surgeons to address the elective, urgent, and emergent needs of their residents. The design of the current payment structure threatens surgical care in several ways. It distorts the true value of complex procedures and services and fails to keep pace with the rising costs of equipment, innovation, staffing, and compliance. Many surgeons are being forced to reduce their Medicare patient load — or exit practice entirely. The result? Longer wait times for routine operations that become complex, or postponed operations that can cause months of preventable pain and worse outcomes. For an aging population, these issues are more than mere inconveniences; they represent life-altering delays that can also increase long-term costs. Safeguarding access to care for those who rely on Medicare should be nonnegotiable. Physicians want to care for patients and their communities and support their colleagues and staff, not face the consequences of a neglected and outdated payment system. Our leaders want high-quality care for their constituents. Congress must pursue real solutions. Bipartisan solutions do exist. We've advocated relentlessly for policies that account for rising costs, including an annual inflationary update to Medicare payment and reforms to requirements for budget neutrality. We both agree these arbitrary restrictions undermine the positive effect of important policy and payment updates, preventing critical investments in primary and surgical care and pitting specialties against one another, all of which fails to prioritize patients and their well-being. Enacting these reforms would do more than stabilize physician practices; it would safeguard access to care for Medicare beneficiaries across the country. The Medicare physician payment system is the scaffolding that supports the health of more than 60 million Americans. And right now, years of neglect are making the foundation crumble. If we want to truly demonstrate we care about patients, we must fix the system that supports the physicians and practices who care for them.
